RI
RTW Investments, LP disclosed a 9.9% stake in STOK
RTW Investments, LP reported owning 9.9% of Stoke Therapeutics, Inc. (STOK) (6,537,475 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G